Search

Syphilis is a sexually transmitted disease. All organs might be affected, but ocular syphilis occurs only in 0.6 percent of patients. A resurgence of syphilis cases has been observed for several years in many countries, especially in HIV-infected subjects. These patients often present with concomitant primary and secondary lesions or extensive presentations of syphilis.We report 2 patients with syphilitic uveitis diagnosed and treated at the department of infectious diseases at the University hospital of Marrakech. Ocular involvement was inaugural in both HIV patients. Each had a specific treatment, but none had a complete recovery of visual function; the first patient was treated by ceftriaxone and the second one was treated by penicillin.Syphilis must be discussed in all patients diagnosed with uveitis or papillitis. The diagnosis should be suspected in cases of eye inflammation even in the absence of favourable clinical presentation or anamnesis. Search for HIV co-infection should be systematic. Although not evidence-based, prompt therapy may lead to functional recovery. Ceftriaxone could be a suitable alternative to penicillin in the treatment of early syphilis in HIV-infected patients. This treatment has a concomitant effectiveness even for asymptomatic forms of neurosyphilis. Ocular syphilis is a form of neurosyphilis and requires neurosyphilis therapy regardless of when it develops after primary infection.Conventional syphilis staging is of little use in understanding ocular syphilis. Co-infection between HIV and ocular syphilis is common, but does not affect response to a neurosyphilis regimen of penicillin in the short term.

Sarcoidosis is a systemic granulomatosis characterized by the formation of epithelioid and giant cell granulomas without caseous necrosis. To make the diagnosis, it is necessary to prove systemic granulomatosis involving at least two organs; but in practice, a combination of clinical, paraclinical and histologic findings is used. It affects predominantly women with a bimodal age distribution: 25-29years and 65-69years. The most commonly affected organs are the mediastinal lymphatic system, lungs, skin and eyes. Ophthalmological involvement is present in 20 to 50% of cases. The typical ocular presentation is that of granulomatous uveitis associated with venous retinal vasculitis and lesions of peripheral multifocal choroiditis. This ophthalmological presentation, although very evocative, is not always associated with systemic disease. The diagnosis of ocular sarcoidosis is then presumed in the absence of histological evidence. Algorithms combining ophthalmological and systemic signs have been proposed in cases of isolated uveitis. They make it possible to establish the diagnosis of ocular sarcoidosis with various levels of probability. The absence of significant granulomas on a systemic level during primary ocular involvement remains the main hypothesis to explain these diagnostic difficulties. Treatment is well described, as the uveitis of sarcoidosis is most often steroid responsive. In the case of corticosteroid-dependent uveitis, the first-line immunosuppressant remains methotrexate. The use of anti-tumor necrosis factor-alpha is an interesting alternative in patients whose ocular sarcoidosis is refractory to conventional immunosuppressants.

The purpose of this case series was to evaluate both the visual and systemic prognosis of patients with endogenous endophthalmitis.We reported a series of 20 cases of endogenous endophthalmitis occurring between 2012 and 2015 at the university medical center in Toulouse.The mean age was 67 (±43.3) years with a male predominance (n=11). The site of entry was found in 14 cases (87.5%). In 11 cases (69%), the causative agent was a bacterium; a fungal infection was found in five cases. Visual acuity after maximal medical and surgical treatment was limited to "no light perception" in 7 cases (35%), "hand motion" in 2 cases (10%), "finger counting" in 3 cases (15%) and 10/10 in 2 cases (10%). One case had no final data. The main site of entry was found to be associated endocarditis (n=7), central venous line or venipuncture (n=6). The main local complications were retinal detachment (n=6), cataract (n=5) and choroidal neovascularization secondary to scarring (n=2).Endogenous endophthalmitis is associated with poor visual prognosis. It is also often associated with systemic complications that may be life-threatening.

To describe a technique for extemporaneously drawing up bevacizumab for intravitreal injection (IVT) and report the rate of post-injection endophthtalmitis.Retrospective monocentric analysis (January 2010-December 2014) of all IVT of bevacizumab drawn up with the following technique: in the operating room (class ISO 7) through a mini-spike with an integrated bacteria retentive air filter. The surgeon was wearing sterile gloves and a mask. The assisting nurse wore a mask. The bevacizumab vial was discarded at the end of each session.Six thousand two hundred and thirty-six bevacizumab injections were performed. One case of endophthalmitis was noted (0.016%). During the same period, 4 cases of endophthalmitis were found after IVT of other drugs (4/32,992; 0.012%. P=0.8).Intravitreal injection of bevacizumab after extemporaneous withdrawal through a mini-spike filter is a simple and safe technique. The risk of postoperative endophthalmitis is very low. This simple technique facilitates access to compounded bevacizumab.

To evaluate epidemiology, diagnostic and therapeutic management strategies and visual outcomes of cases of bacterial and fungal endogenous endophthalmitis managed in the Nice University Medical Center between January 2000 and June 2015.Three hundred twenty-three charts of patients with endophthalmitis treated at the Nice University Medical Center over this period were retrospectively reviewed to select the ones with endogenous endophthalmitis. Demographic characteristics, medical history, clinical presentation, diagnostic and therapeutic management, microbiology, and final outcomes were analyzed.Twenty-two eyes of 20 patients were selected, constituting 6.20% of all cases of endophthalmitis. The mean age was 69years, and 75% of patients were male. The most common risk factors were diabetes, malignancies and cardiac diseases. Bacterial isolates were found in 16 cases (80%), fungal isolates in 3 (15%) and co-infection in 1 case. Gram-positive organisms accounted for 70.6% of cases (mostly Staphylococcus aureus [25%], Streptococcus agalactiae [25%] and Streptococcus pneumoniae [16.7%]). Candida albicans was the most common fungal organism. There was one bacterial and fungal co-infection. Two patients died, 4 eyes were enucleated or eviscerated (20%), and 4 patients (20%) attained a final visual acuity of 1/10 or better.Endogenous endophthalmitis is a rare and serious condition with a poor prognosis. Gram-positive microorganisms, mostly S. aureus, were the main causative pathogens found.

Post-traumatic endophthalmitis is a rare but serious complication of open globe injury, representing a major turning point for the patient's visual prognosis. Risk factors for this complication are lens capsule rupture, an intraocular foreign body, type of eye trauma and especially a delay in initial management of the trauma. Although Staphylococcus epidermidis is the most common organism, as in postoperative acute endophthalmitis, other microorganisms are more frequently represented and the multi-microbial involvement is common. The diagnosis can be difficult in the presence of inflammatory signs of trauma. Aside from rapid globe repair, neither preventive nor curative treatment have been well delineated. The class of antibiotics, the dosage, route of administration, as well as surgical treatment by vitrectomy remain topics of discussion.

To report the anatomical and functional outcomes after endoscopy-guided vitrectomy in a series of cases of severe endophthalmitis. Also to identify and compare the outcomes of two different modes of clinical presentation.Retrospective case study, single center; all patients who underwent endoscopic 20Ga vitrectomy (Endo optiks E4 system) for severe endophthalmitis were included. For each case, data were recorded for: etiology, surgical indication, preoperative and postoperative visual acuity, comorbidity factors and postoperative complications, and whether any additional surgery was performed. Two groups were distinguished according to their initial mode of presentation; results were then compared in terms of complications and visual prognosis to those found in the literature.Eighteen patients were included, with mean age 62±19years. Severe endophthalmitis was initially obvious for 8 cases (group 1). For 10 cases, disease progression had been considered unfavorable despite adequate medical treatment (group 2). There was no statistically significant difference between the two groups (P=0.55). Endophthalmitis occurred: after intravitreal injections (4 cases), after intraocular foreign body (n=2), after cataract surgery (n=5), following a trabeculectomy (n=2), after epiretinal membrane peeling (n=3), 1 case caused by a corneal infection and 1 case of endogenous leptospirosis. Mean follow-up was 13.7months. The surgical technique was a complete 20Ga vitrectomy under endoscopic visual control. The mean operative time was 70±27minutes. The causative organism was identified in 72% of cases in vitreous humor samples, among which 77% were gram-positive organisms. The infection was controlled in 89% of cases, and these patients have recovered useful visual acuity.The value of endoscopic visualization in ophthalmology has been proven for 30 S. aureus years, but its miniaturization enhances the current enthusiasm for the use of this instrumentation. When visualization is compromised, endoscopic guided vitrectomy is very useful and may assist the surgeon in the management of these difficult cases. Our anatomical and functional outcomes are encouraging, but we must keep in mind the poor long-term prognosis of severe endophthalmitis.

To investigate the microbiological profile of acute postoperative endophthalmitis in a referral center in Tunisia and to assess the antibiotic sensitivity of the organisms.This is a retrospective study over a period of eleven years, conducted on patients hospitalized with acute infectious postoperative endophthalmitis. Cultures were performed on aqueous (93%) and vitreous specimens (68%) obtained at presentation. Each sample underwent direct examination, culture and antibiotic susceptibilities.The number of acute postoperative endophthalmitis cases identified during the study period was 308. Organisms were found in 43% of samples (endophthalmitis was bacterial in 39.5%, fungal in 0.9% and polymicrobial in 2.6%). Cultures grew primarily Staphylococcus epidermidis in 31.4% of cases, Streptococcus pneumoniae in 22.7% of cases and Staphylococcus aureus in 12.7% of cases. Gram-positive cocci are more sensitive to vancomycin and Gram-negative bacilli are more susceptible to ofloxacin and ciprofloxacin.In our study, microbiological samples were positive in 43% and coagulase-negative Gram-positive cocci are the most common organisms. However, antibiotic resistance has been increasing over the years.

Ocular involvement by Candida albicans is rare and may present as endogenous endophthalmitis or choroiditis. It occurs in the context of C. albicans septicemia, in the context of intensive care unit hospitalization or intravenous drug use. We report two cases referred to our department with different characteristics, background, diagnostic modalities and different courses.A 37-year-old woman, with a history of intravenous drug use, presented with C. albicans endophthalmitis. Intravenous combination antifungal therapy was begun, but vitrectomy and intravitreal amphotericin B were performed due to worsening of the endophthalmitis. The second case was a 53-year-old man who was hospitalized in the intensive care unit for C. albicans septicemia with a left macular chorioretinitis. Intravenous antifungal therapy was initiated and allowed regression of the ocular lesion.Our cases illustrate both types of ophthalmic involvement by candidiasis requiring different treatments with well-described recommendations: in the case of endophthalmitis, the use of vitrectomy and intravitreal amphotericin B injection in association with intravenous antifungal treatment, whereas parenteral antifungal treatment is often sufficient in the case of chorioretinitis.Early detection, initiation of treatment and ophthalmologic monitoring are difficult but necessary in these populations non-compliant with follow-up or in intensive care units. The management of ocular candidiasis requires good collaboration between the ophthalmology, infectious diseases and intensive care unit departments.

Endophthalmitis is the most dreaded complication after intravitreal injection. With the rise of antiangiogenics their rate is getting higher each year. The use of antibioprophylaxis is controversial. We tried to evaluate the impact of antibioprophylaxis on intravitreal injection endophthalmitis incidence.All patients who received intravitreal injections between January 2007 and October 2012 were included in this retrospective study. Until June 2012 all patients had antibiotics the days following the injection. From July 2012 the antibiotic was replaced by an antiseptic immediately after the injection.An overall number of 11,450 injections were performed. The overall rate of endophthalmitis was 6/11,450 (0.052%). The incidence of endophthalmitis in the group with antibiotics was 3/10,144 injections (0.03%), 2 were culture proven (0.02%). The incidence in the group without antibiotics was 3/1306 (0.23%). The difference was significant (P=0.024).The incidence of endophthalmitis post-intravitreal injections seems to be lower when using antibiotics. However, a prospective study is mandatory to draw more robust conclusions.

Endogenous endophthalmitis is a devastating infection of the eye that leads to blindness in about two-thirds of patients. It results from the haematogenous spread of a microorganism from a focus of sepsis, mainly gastro-intestinal, genitourinary or cardiac.We describe the case of a diabetic subject presenting endogenous endophthalmitis following erysipelas of the leg due to Streptococcus agalactiae. The outcome was favourable thanks to prompt initiation of appropriate antibiotic treatment.Endogenous endophthalmitis as a complication of a skin infection is a rare entity, with only about 30 reported cases in the literature. Awareness of this condition among dermatologists would allow prompt intervention, which is essential for sparing of the patient's eyesight.

Endophthalmitis remains the main complication of intravitreal injections, especially because their repetition multiplicates the risks. Surgical antisepsis is required for the prevention of endophthalmitis, but the benefit/risk ratio of topical antibioprophylaxis has never been demonstrated. In contrast, the selection of resistant bacteria appears to be exponential with the wider use of topical antibioprophylaxis. It seems that more and more operators stop using anibioprophylaxis, provided that the antisepsis is surgical and that the injection is performed in accordance with the rules of good practice.

Purpose. Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects. Taking into account the opposing needs of limiting parasite multiplication and minimizing tissue destruction, the immune imbalance implies especially Th17 and T regulatory (Treg) cells.Methods. In a prospective clinical study of acute intraocular inflammation including ocular toxoplasmosis, viral uveitis, systemic inflammatory disease related uveitis and bacterial endophthalmitis we evaluated the cytokine pattern in aqueous humors of affected patients. To further study the immunological mechanisms involved during ocular toxoplasmosis, weevaluated the intraocular inflammation, the parasite load and the immunological response characterized on mRNA and protein level in a mouse model. To evaluate the role of IL-17A, anti IL-17A monoclonal antibodies (mAbs) were administered concomitantly with the parasite.Results. Cytokines networks are different, depending on the cause of intraocular inflammation. In OT, we observed severe ocular inflammation and cytokine patterns comparable to human cases, including IL-17A production. Neutralizing IL-17A decreased intraocular inflammation and parasite load in mice. Detailed studies revealed upregulation of Treg and Th1 pathways. When IFN-γ was neutralized concomitantly, the initial parasite multiplication rate was partially restored.Conclusions. Local IL-17A production plays a central role in pathology of OT. The balance of Th17 and Th1 responses (especially IFN-γ) is crucial for the outcome of infection. These data open new in vivo therapeutic approaches by repressing inflammatory pathways using intravitreal injection of IL-17A mAbs.; Introduction. La toxoplasmose oculaire (TO) est la première cause d’uvéite postérieure. L’évolution de cette pathologie dépend d’une balance entre la régulation de la réponse immunitaire et la limitation de la prolifération parasitaire.Méthodes. Le but de nos travaux est de déterminer le spectre des cytokines dans l’humeur aqueuse de patients une To ou une autre inflammation intraoculaire (uvéite d’étiologies virales ou secondaires à des maladies inflammatoires systémiques et endophtalmie bactérienne). Pour mieux appréhender les mécanismes immunitaires mis en jeu lors d’une TO, des dosages de transcrits par RT-PCR et de protéines inflammatoires par immunoessaimultiplexe sont réalisés à partir de modèles murins de TO. Enfin, l’effet de l’injection intraoculaire d’anticorps (AC) anti-IL-17A sur l’inflammation intraoculaire et la prolifération parasitaire est étudié.Résultats. Les spectres de cytokines observés dans l’humeur aqueuse diffèrent nettement en fonction de la cause de l’inflammation. Plus particulièrement, IL-17A semble jouer un rôle primordial dans la pathogénicité de la TO humaine et murine. Chez la souris infectée, l’inflammation intraoculaire et le nombre de parasites intraoculaires sont diminués parl’administration d’AC anti-IL-17A. Les niveaux d’ARNm de T-bet et Foxp3, ainsi que la concentration en IFN-γ (marqueurs de l’immunité cellulaire de type Th1 et Treg), sont augmentés après l’injection d’AC anti-IL-17A.Discussion. Les AC anti-IL-17A modèrent la réponse inflammatoire intraoculaire et limitent la prolifération parasitaire en antagonisant les cellules Th17, probablement via l’induction des cellules Th1 et Treg, secrétant IL-10 et IL-27. Ces résultats préliminaires suggèrent une nouvelle approche thérapeutique in vivo lors d’une toxoplasmose oculaire.

Purpose. Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects. Taking into account the opposing needs of limiting parasite multiplication and minimizing tissue destruction, the immune imbalance implies especially Th17 and T regulatory (Treg) cells.Methods. In a prospective clinical study of acute intraocular inflammation including ocular toxoplasmosis, viral uveitis, systemic inflammatory disease related uveitis and bacterial endophthalmitis we evaluated the cytokine pattern in aqueous humors of affected patients. To further study the immunological mechanisms involved during ocular toxoplasmosis, weevaluated the intraocular inflammation, the parasite load and the immunological response characterized on mRNA and protein level in a mouse model. To evaluate the role of IL-17A, anti IL-17A monoclonal antibodies (mAbs) were administered concomitantly with the parasite.Results. Cytokines networks are different, depending on the cause of intraocular inflammation. In OT, we observed severe ocular inflammation and cytokine patterns comparable to human cases, including IL-17A production. Neutralizing IL-17A decreased intraocular inflammation and parasite load in mice. Detailed studies revealed upregulation of Treg and Th1 pathways. When IFN-γ was neutralized concomitantly, the initial parasite multiplication rate was partially restored.Conclusions. Local IL-17A production plays a central role in pathology of OT. The balance of Th17 and Th1 responses (especially IFN-γ) is crucial for the outcome of infection. These data open new in vivo therapeutic approaches by repressing inflammatory pathways using intravitreal injection of IL-17A mAbs., Introduction. La toxoplasmose oculaire (TO) est la première cause d’uvéite postérieure. L’évolution de cette pathologie dépend d’une balance entre la régulation de la réponse immunitaire et la limitation de la prolifération parasitaire.Méthodes. Le but de nos travaux est de déterminer le spectre des cytokines dans l’humeur aqueuse de patients une To ou une autre inflammation intraoculaire (uvéite d’étiologies virales ou secondaires à des maladies inflammatoires systémiques et endophtalmie bactérienne). Pour mieux appréhender les mécanismes immunitaires mis en jeu lors d’une TO, des dosages de transcrits par RT-PCR et de protéines inflammatoires par immunoessaimultiplexe sont réalisés à partir de modèles murins de TO. Enfin, l’effet de l’injection intraoculaire d’anticorps (AC) anti-IL-17A sur l’inflammation intraoculaire et la prolifération parasitaire est étudié.Résultats. Les spectres de cytokines observés dans l’humeur aqueuse diffèrent nettement en fonction de la cause de l’inflammation. Plus particulièrement, IL-17A semble jouer un rôle primordial dans la pathogénicité de la TO humaine et murine. Chez la souris infectée, l’inflammation intraoculaire et le nombre de parasites intraoculaires sont diminués parl’administration d’AC anti-IL-17A. Les niveaux d’ARNm de T-bet et Foxp3, ainsi que la concentration en IFN-γ (marqueurs de l’immunité cellulaire de type Th1 et Treg), sont augmentés après l’injection d’AC anti-IL-17A.Discussion. Les AC anti-IL-17A modèrent la réponse inflammatoire intraoculaire et limitent la prolifération parasitaire en antagonisant les cellules Th17, probablement via l’induction des cellules Th1 et Treg, secrétant IL-10 et IL-27. Ces résultats préliminaires suggèrent une nouvelle approche thérapeutique in vivo lors d’une toxoplasmose oculaire.

Due to the need for treatment guidelines for endophthalmitis in impoverished areas, we have formulated an approach which takes into account pharmacokinetic data, keeping in mind that, whether oral or intramuscular, antibiotics must achieve therapeutic intraocular levels, antibiotic susceptibility of the most common pathogens in endophthalmitis, and routine availability of bioequivalent generics in the areas in question. In this work, we present the basic guidelines for the management of postoperative endophthalmitis by ophthalmology services in impoverished areas.

Transconjunctival sutureless vitrectomy is a recent advance in vitreoretinal surgery. Some authors have reported an increased risk of postoperative hypotony and endophthalmitis and recommend the creation of oblique incisions, intended to be self-sealing, so as to reduce these risks. However, there is still a debate about the best architecture for transconjunctival sutureless incisions.We report two cases of acute endophthalmitis occurring after 23 and 25 gauge transconjunctival sutureless vitrectomy. We analyzed the scleral incisions using the anterior segment module of the Spectralis(®) OCT. To our knowledge, this is the first direct description of the appearance of sclerotomies associated with endophthalmitis.The anterior segment module of Spectralis(®) OCT permitted a high-resolution evaluation of the architecture of the scleral incisions. We found straight, gaping incisions with misaligned edges and vitreous incarceration.By way of these two case reports and a review of the literature, we discuss the contribution of anterior segment OCT in the analysis of scleral incision architecture in sutureless vitrectomy. Our findings are consistent with those reported in the literature. The presence of a direct incision, wound gap or edge misalignment are associated with an increased risk of early leakage and postoperative hypotony.The anterior segment module of the Spectralis(®) OCT is a valuable tool for non-invasive, painless and high-resolution documentation of sutureless vitrectomy incisions. It allows for causal analysis and better understanding of the conditions associated with endophthalmitis after sutureless vitrectomy.

Intravitreal injections are very commonly performed in the daily practice of Ophthalmology and become a leading procedure in the management of age-related macular degeneration, diabetic retinopathy, infectious endophthalmitis or retinitis, uveitis and retinal vein occlusions. Based on the comments of a group of experts, including ophthalmologists, pharmacists and hygienists, the French Agency for the Safety of Health Products (AFSSAPS) edited a guide to good practice of intravitreal injections, revisiting those previously published in 2006. The overall experience accumulated during time is a valuable source of information to determine the most appropriate protocol. Therefore, the simplification of the procedure is reasonably proposed even though safety remains a major issue, in order to avoid complications, especially infections.

Staphylococcus aureus (S. aureus) is a frequent cause of acute endophthalmitis and arthritis in humans. In the first part, we investigated the ocular pharmacodynamics and safety of two recently approved antistaphylcoccal antibiotics, linezolid and daptomycin. Only a very high intravitreal dose of linezolid (30 mg / 0.1 mL) showed a bactericidal and clinical efficacy. Suchintraocular concentrations appeared to be safe for the retinal function, and linezolide could be considered as a promising therapeutic alternative. The effective intravitreal dose of daptomycin (1 mg / 0.1 mL) was responsible for a significant impairment of the functional integrity of the retina. Finally, the ocular pharmacodynamics of these two antibiotics showed special features in comparison with the one of other types of tissue infection. In a second part, we evaluated a newimaging method in experimental infectious arthritis, by using MRI enhanced by ultrasmall superparamagnetic iron oxide (USPIO). We first showed this method can depict the macrophage infiltration in infected synovium, and secondly it can demonstrate resolution of joint infection, in contrast to conventional MRI performed by gadolinium chelates. This in vivo non invasive imaging method therefore presents a new dimension in musculoskeletal imaging by accurately helping monitor bacterial joint infection., Staphylococcus aureus est une des espèces bactériennes les plus fréquemment responsable des cas d’endophtalmie et d’arthrite aiguës chez l’homme. Nous avons étudié la pharmacodynamie oculaire du linézolide et de la daptomycine, ainsi que leur toxicité, dans un modèle d’endophtalmie expérimentale chez le lapin. Il est apparu que seule une dose très élevée delinézolide administrée par voie intravitréenne (30mg/0,1mL) présentait une efficacité bactérioclinique. Aucune altération de la fonction visuelle n’a été mise en évidence. La dose intravitréenne efficace de daptomycine (1mg/0,1mL) était quant à elle responsable d’une altération significative de l’intégrité fonctionnelle de la rétine. Enfin, la pharmacodynamie de ces deux antibiotiques dans le compartiment oculaire présentait des différences significatives avec les autres sites tissulaires d’infection étudiés à ce jour. Dans la deuxième partie de nos travaux nous nous sommes intéressés à une nouvelle technique d’IRM, associée à des particules d’USPIOs (Ultrasmall SuperParamagnetic Iron Oxide). Nous avons montré que cette techniqued’imagerie permettait d’une part la mise en évidence de l’infiltration des macrophages dans la synoviale infectée, et, d’autre part, la visualisation de la guérison de l’articulation, contrairement à l’imagerie conventionnelle à base de chélates de gadolinium. Cette technique innovante offre donc une nouvelle dimension à l’imagerie ostéo-articulaire grâce à une mise en évidence in vivo plus spécifique des phénomènes pathologiques.

According to the literature and to the advice of experts, the French Agency for the Safety of Health Products (AFSSAPS) edited recommendations about the antibioprophylaxis in ocular surgery. One goal was to avoid the extensive use of oral and topical fluoroquinolones in antibioprophylaxis, in order to preserve their antibacterial activity for curative treatments of severe eye infections. The medical team decides for the indication and the type of antibioprophylaxis for each patient. A topical antibiotic is recommended for any eye surgery until the etancheity of incisions. Due to the risk of selection of bacterial resistance topical fluoroquinolones are not recommended in this indication. In open eye surgery, an additional antibioprophylaxis is recommended: in cataract surgery, injection in the anterior chamber at the end of the procedure of 1mg of cefuroxime; in other open eye surgeries, only in case of risk factors for endophthalmitis, administration of 500 mg oral levofloxacin tablet 12 hours and two hours before surgery. For ocular punctures and intravitreal injections, only a topical postoperative antibiotic is recommended until healing.

In this study, rifampicin-loaded microparticles were designed for intra ocular injection after cataract surgery to prevent postoperative endophthalmitis. Microparticles were produced by emulsification diffusion method using PLGA as biodegradable polymer and PVA as stabilizer agent. Influence of formulation and process parameters on microparticle characteristics (size, zeta potential, encapsulation efficiency…) was firstly investigated. Main parameters influencing the properties of particles were then identified by experimental design and formulation parameters were optimized to get desired particle sizes for intraocular delivery (between 1 and 10 μm) and the highest encapsulation of rifampicin. In vitro release studies of rifampicin in BSS at 37°C were performed showing firstly a burst release in 1 hour (more than 50% of rifampicin released), followed by a sustained release with a rifampicin concentration in the medium higher than the ICM50 on Staphylococcus epidermidis during 24h. Finally, the antimicrobial efficiency of rifampicin microparticles was evaluated on S. epidermidis. The results showed a higher bactericidal effect of encapsulated rifampicin than the control rifampicin solution; no bacteria were retrieved after 30h in the medium. Moreover, the antiadhesive property of rifampicin microparticles on intraocular lens (IOLs) was demonstrated since no bacteria were found on IOLs after 18h of incubation. From these experimental results, rifampicin encapsulated polymeric microparticles seem to be a good candidate for intraocular delivery of rifampicin in postoperative endophthalmitis prophylaxis, Des microparticules de rifampicine pour l'administration intraoculaire ont été développées en vue du traitement prophylactique de l'endophtalmie post-chirurgicale. Ces microparticules à base d'un polymère biodégradable, le PLGA, sont produites par émulsion-diffusion. Tout d'abord l'influence des paramètres de formulation et de procédé sur les caractéristiques des microparticules (taille, charge, taux d'encapsulation…) a été étudiée. La formulation a par la suite pu être optimisée par la mise en place d'un plan d'expérience, ce qui a permis de mettre en valeur les paramètres clefs influençant les propriétés des microparticules (concentrations en PLGA et PVA, présence ou non d'un coeur huileux…) et donc d'optimiser la formulation pour obtenir des microparticules adéquates pour l'administration intraoculaire de rifampicine (1μm CMI50 de Staphylococcus epidermidis (pathogène modèle utilisé pour les études microbiologiques). Enfin, une évaluation de l'effet bactéricide et antiadhérent sur lentilles intraoculaires (IOLs) de la rifampicine microencapsulée a été menée en présence de S. epidermidis. Les microparticules de rifampicine présentent une efficacité nettement supérieure à la solution contrôle de rifampicine puisque une bactéricidie totale a pu être observée 30h après injection (contre 103 CFU/mL restantes avec la solution contrôle), avec une activité antiadhérente nettement plus marquée (aucune bactérie détectée sur IOLs après 18h). Les microparticules de rifampicine apparaissent donc comme système d'administration intraoculaire prometteur dans le traitement prophylactique de l'endophtalmie post-opératoire

To study and discuss the epidemiological, clinical, microbiological, and risk factors of bacterial endophthalmitis treated in the Rabat Specialty Hospital ophthalmology department.This is a retrospective study over a period of 10 months of patients hospitalized for suspected acute infectious endophthalmitis. An intake form was completed for each patient. Each sample underwent direct examination and culture. All patients underwent the same protocol, providing for at least one intravitreal antibiotic injection and instillation of fortified eye drops.Twenty cases of endophthalmitis were recorded during the study period. Decreased visual acuity, intraocular inflammation, pain and conjunctival hyperemia were found in all patients. The median onset of symptoms was 4 days. Vitreous tap or anterior chamber paracentesis was performed in all patients. Bacteria were found in seven samples (40%). Gram positive organisms accounted for 85% of positive cultures. Amphotericin B was required in four patients, and systemic antibiotic therapy in ten patients. Corticosteroid treatment was administered secondarily in eight patients.In this retrospective series, epidemiological, clinical and microbiological data are consistent with those already published.

Endogenous bacterial endophthalmitis (EBE) is an intraocular bacterial infection transmitted via a hemotogenous route, usually occuring in immunocompromised patients with bacteremia spreading from extraocular foci of infection. We report a case of EBE secondary to a dental infection occurring in an immunocompetent patient.A 61-year-old-man with no past medical history other than a dental bridge on the 13th tooth was referred for rapid onset hypertensive fibrinous panuveitis of the right eye. He presented with profound visual loss in this eye, an absent pupillary reflex and an obscured fundus. The left eye was normal. Neither fever nor constitutional symptoms were noted at presentation. Work-up revealed a mild inflammatory syndrome with increased C-reactive protein, a high antistreptolysin O titer, and an abscess of the dental bridge. The clinical picture worsened rapidly, suggesting the possibility of EBE secondary to an organism of dental origin. Aqueous humor polymerase chain reaction (PCR) was positive for streptococci, which could not be identified more specifically. Removal of the dental bridge in combination with systemic and intravitreal multiple antiobiotic therapy achieved a rapid cure of the EBE. Vitrectomy combined with phacoemulsification was performed later in order to clear media opacities. At 6 months follow-up, best-corrected visual acuity was 8/10 with no recurrent inflammation.This case shows that EBE can occur in the absence of predisposing factors but with an extraocular infectious focus as simple as a dental abscess. In the absence of associated septicemia, with the involved tooth superior and ipsilateral to the affected eye, a spread of the infection by retrograde venous flow should be suspected. The prognosis for visual function may be good if early diagnosis and immediate treatment can be provided.

Results of surgery for congenital cataract were studied according to age of implantation, type and polarity. Each forms combined, visual acuity in logMAR is divided by a median of 0.45 (5/10) in bilateral cataracts and 0.7 (2/10) in the unilateral. The precocity of the surgery allows a better prognosis, but exposes to more complications, especially glaucoma. Complications as inflammatory diseases, glaucoma, capsular opacification, refractive error, residual myopic shift, and retinal complications are discussed.

Endogenous endophthalmitis of bacterial or fungal origin is a rare condition, accounting for 5 to 10% of all endophthalmitis cases. Different risk factors have been identified and ocular involvement is usually due to one or multiple systemic infectious abscesses with variable virulence. Clinical symptoms may initially mimic a panuveitis and will delay diagnostic confirmation. Ancillary tests will determine the infectious source and isolate the causative agent. Specific therapy is based on systemic and intravitreal antibiotics or antifungals associated with a pars plana vitrectomy in severe cases. Despite an aggressive therapeutic strategy, visual prognosis remains guarded. Education of ophthalmologists and infectious disease specialists may decrease diagnostic delay so that specific antimicrobial agents can be initiated promptly and thus avoid a permanent blindness.

Endogenous bacterial endophthalmitis, also called metastatic bacterial endophthalmitis, remains a diagnostic and therapeutic challenge. It is a rare and potentially sight-threatening ocular infection that occurs when bacteria reach the eye via the bloodstream, cross the blood-ocular barrier, and multiply within the eye. It usually affects immunocompromised patients and those suffering from diabetes mellitus, malignancy, or cardiac disease, but has also been reported after invasive procedures or in previously healthy people. In most cases, the ocular symptoms occur after the diagnosis of septicemia or systemic infection. Ocular symptoms include decreased vision, redness, discharge, pain, and floaters. The ocular inflammatory signs may be anterior and/or posterior. Bilateral involvement occurs in nearly 25% of cases. A wide range of microorganisms are involved, with differences in their frequency according to geography as well as the patient's age and past medical history, because of variations in the predisposing conditions and the source of the sepsis. The majority of patients are initially misdiagnosed, and ophthalmologists should be aware of this because prompt local and general management is required to save the eye and/or the patient's life.

Toxic anterior segment syndrome (TASS) is a general term used to describe acute, sterile postoperative inflammation due to a non-infectious substance that accidentally enters the anterior segment at the time of surgery and mimics infectious endophthalmitis. TASS most commonly occurs acutely following anterior segment surgery, typically 12-72h after cataract extraction. Anterior segment inflammation is usually quite severe with hypopyon. Endothelial cell damage is common, resulting in diffuse corneal edema. No bacterium is isolated from ocular samples. The causes of TASS are numerous and difficult to isolate. Any device or substance used during the surgery or in the immediate postoperative period may be implicated. The major known causes include: preservatives in ophthalmic solutions, denatured ophthalmic viscosurgical devices, bacterial endotoxin, and intraocular lens-induced inflammation. Clinical features of infectious and non-infectious inflammation are initially indistinguishable and TASS is usually diagnosed and treated as acute endophthalmitis. It usually improves with local steroid treatment but may result in chronic elevation of intraocular pressure or irreversible corneal edema due to permanent damage of trabecular meshwork or endothelial cells.

Chronic postoperative endophthalmitis designates delayed-onset postoperative endophthalmitis appearing more than two weeks after surgery, revealed by chronic intraocular inflammation with phases of inflammatory recurrence, which, at the beginning of the disease course, is partially sensitive to local corticosteroid treatment. It differs therefore from acute endophthalmitis in the immediate postoperative phase, from acute differed endophthalmitis after filtrating surgery, which appears years after the surgery, and from endogenous endophthalmitis. The most frequent presentation is granulomatous uveitis, often hypertonic, in an eye operated for cataract, presenting phases of recurrence sensitive to corticosteroid therapy but which recurs as soon as treatment is interrupted. Whitish condensations in plaques on the posterior capsule suggest the diagnosis and over several months the vitreous becomes inflamed. Ocular samples allow cytological analysis of an infectious process and bacteriological analysis in culture and with PCR. Treatment includes lavage of the sac with vancomycin and can be associated with posterior capsulectomy and intravitreal injections of antibiotics possibly associated with systemic antibiotic therapy. Treatment is prolonged because of the slow replication of the microorganisms involved. In approximately one-third of cases, the implant, the capsule, and the sac must be removed over 360° to permanently halt the intraocular infection. The diagnosis and specific treatment should be as early as possible since the aggressiveness of the treatment required is correlated with the time to management of the infection.

Endophthalmitis is one of the leading sources of dispute in ophthalmology. The patient has a number of means to make an appeal. Fortunately, appeal to the criminal justice system is rare in medicine, but always possible (e.g., indictment for endangering the life of others or for involuntary injury). Civil action is more frequent, allowing the patient to recover damages in case of negligence on the part of the surgeon. Finally, the law of March 4th 2002 allows the CRCI to award an indemnity to patients if the surgeon is not at fault, but in certain conditions only. The knowledge of the surgeon's obligations and the means of appeal available to the patient is very useful for the ophthalmologist.

To evaluate intravitreal bevacizumab therapy for choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD).A retrospective review between June 2006 and May 2008 of patients with CNV secondary to AMD was conducted. All patients were treated with intravitreal injection of bevacizumab (1.25mg) once a month during a 3-month-period. The mean evaluation criteria were the best-corrected visual acuity (BCVA) logMar testing before and one month after the third injection. All eyes underwent an angiography and an optical coherence tomography before injections to define the activity and the type of CNV and then to evaluate the persistence of leakage (macular edema, subretinal fluid, and pigment epithelial detachment) after treatment. Then treatments were left to the investigator's discretion during the following six months.Seventy-one eyes of 66 patients were enrolled. There were 65% occult CNV, 20% classic CNV, and 15% combined. A significant improvement in BCVA was observed, from 0.88±0.57 to 0.77±0.60 (p=0.001), one month after the third injection. At this time, 57.7% of the eyes required a reinjection because of leakage persistence. A concomitant treatment with intravitreal triamcinolone injection and/or photodynamic therapy was necessary for 8% of nonresponder eyes. Six months after initial treatment, a complete resolution of exudative signs was not obtained for 33.8% of eyes. The average number of injections was 3.85±0.96 during the 9-month follow-up. BCVA stability was observed at 4, 6 and 9-month follow-ups (F(71.2)=1.54; p=0.46). Three complications occurred: one endophthalmitis, one retinal tear, and one vitreous hemorrhage secondary to a macular hemorrhage.Mean BCVA significantly improved at one month after three consecutive monthly intravitreal injections of bevacizumab. However, most eyes required a reinjection.In spite of improvement in BCVA, leakage of the CNV persisted in most eyes after three monthly intravitreal injections of bevacizumab. Then retreatment and sometimes concomitant treatment was necessary to obtain complete resolution of exudative signs and BCVA stability.